Evidence map›Paper›PMID 41890361›Full record

ArticleNeuro-oncology advances

Disturbance of functional connectivity in patients with low grade glioma is associated with worse progression-free survival.

Veit M Stoecklein, Stephan Wunderlich, Jonathan Weller, Boris Papazov, Stefan Suvak, Sophie Katzendobler, Michael Schmutzer-Sondergeld, Christian Schichor, Niklas Thon, Louisa Von Baumgarten and 6 more

Abstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Veit M StoeckleinDepartment of Neurosurgery, LMU University Hospital, Munich, Germany.ORCID https://orcid.org/0000-0001-6206-0621
Stephan WunderlichDepartment of Radiology, LMU University Hospital, Munich, Germany.
Jonathan WellerDepartment of Neurosurgery, LMU University Hospital, Munich, Germany.
Boris PapazovDepartment of Radiology, LMU University Hospital, Munich, Germany.
Stefan SuvakDepartment of Radiology, LMU University Hospital, Munich, Germany.
Sophie KatzendoblerDepartment of Neurosurgery, LMU University Hospital, Munich, Germany.
Michael Schmutzer-SondergeldDepartment of Neurosurgery, LMU University Hospital, Munich, Germany.
Christian SchichorDepartment of Neurosurgery, LMU University Hospital, Munich, Germany.ORCID https://orcid.org/0000-0001-6684-3578
Niklas ThonDepartment of Neurosurgery, LMU University Hospital, Munich, Germany.
Louisa Von BaumgartenDepartment of Neurosurgery, LMU University Hospital, Munich, Germany.ORCID https://orcid.org/0000-0002-6634-0927
Darius KalasauskasDepartment of Neurosurgery, LMU University Hospital, Munich, Germany.
Patrick N HarterCenter for Prion Research and Neuropathology, Ludwig-Maximilians-University, Munich, Germany.
Jens RickeDepartment of Radiology, LMU University Hospital, Munich, Germany.
Thomas LiebigDepartment of Neuroradiology, LMU University Hospital, Munich, Germany (T.L.).
Florian RingelDepartment of Neurosurgery, LMU University Hospital, Munich, Germany.
Sophia StoeckleinDepartment of Radiology, LMU University Hospital, Munich, Germany.ORCID https://orcid.org/0000-0003-0325-4674

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Low grade glioma (LGG) is a disease associated with survival >10 years in most cases. Some patients, however, do not respond well to treatment and exhibit early progression as well as low overall survival. It is a challenge to identify these at-risk patients. Here, we used resting-state functional MRI (rsfMRI) to identify patients with LGG at risk for poor clinical outcome. Methods: Twenty-five patients with suspected LGG were prospectively enrolled. All patients underwent rsfMRI before any invasive procedure. Patient data was compared to a reference cohort of 1000 healthy controls to determine abnormality of functional connectivity on an individual level, resulting in a relative numerical measure called the dysconnectivity index (DCI). A median split was performed in order to divide the cohort into 2 groups with low and high DCI, respectively. Progression-free survival (PFS) as a primary outcome measure was calculated in both groups. Results: Twelve patients were diagnosed with astrocytoma, IDH-mutated, CNS WHO grade 2, and 13 patients were diagnosed with oligodendroglioma, IDH-mutated, 1p/19q-codeleted, CNS WHO grade 2. Eight patients had tumor progression, and 2 patients died during the observation period. 1/12 patients in the low DCI group and 7/13 patients in the high DCI group had tumor progression, resulting in significantly shorter PFS for patients with high DCI ( Conclusion: Greater disturbance of functional connectivity at the time of diagnosis as determined by rsfMRI was associated with shorter PFS in our cohort of patients with LGG. This suggests that rsfMRI might be used to identify LGG patients who are at risk of poor clinical outcome.

Indexed as

connectivitygliomalow graderesting state ­functional MRI

Identifiers

PMID41890361
PMCPMC13012875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.